KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Thermo Fisher Scientific (TMO) Acquisitions (2016 - 2026)

Thermo Fisher Scientific filings provide 17 years of Acquisitions readings, the most recent being $8.9 billion for Q1 2026.

On a quarterly basis, Acquisitions changed N/A to $8.9 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $8.9 billion, a 183.27% increase, with the full-year FY2025 number at $4.0 billion, up 28.9% from a year prior.
Acquisitions hit $8.9 billion in Q1 2026 for Thermo Fisher Scientific, up from $3.1 billion in the prior quarter.
In the past five years, Acquisitions ranged from a high of $8.9 billion in Q1 2026 to a low of -$1.0 million in Q4 2022.
Median Acquisitions over the past 4 years was $909.0 million (2023), compared with a mean of $2.2 billion.
Biggest five-year swings in Acquisitions: crashed 101.06% in 2022 and later soared 91000.0% in 2023.
Thermo Fisher Scientific's Acquisitions stood at -$1.0 million in 2022, then soared by 91000.0% to $909.0 million in 2023, then skyrocketed by 244.55% to $3.1 billion in 2024, then soared by 183.27% to $8.9 billion in 2026.
The last three reported values for Acquisitions were $8.9 billion (Q1 2026), $3.1 billion (Q3 2024), and $909.0 million (Q3 2023) per Business Quant data.